Cargando…
Cost-Comparison Analysis of a Physician-Delivered Step-Count Prescription Strategy
BACKGROUND: Increments of 1000 steps/d predict cardiovascular disease (CVD) event reductions. In adults with type 2 diabetes and/or hypertension, our Step Monitoring to Improve Arterial Health (SMARTER) trial demonstrated a physician-delivered step-count prescription strategy to increase steps by mo...
Autores principales: | Sangarapillai, Tarsan, Hajizadeh, Mohammad, Daskalopoulou, Stella S., Dasgupta, Kaberi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413227/ https://www.ncbi.nlm.nih.gov/pubmed/34505044 http://dx.doi.org/10.1016/j.cjco.2021.04.009 |
Ejemplares similares
-
Step Monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods
por: Dasgupta, Kaberi, et al.
Publicado: (2014) -
Physician step prescription and monitoring to improve ARTERial health (SMARTER): A randomized controlled trial in patients with type 2 diabetes and hypertension
por: Dasgupta, Kaberi, et al.
Publicado: (2017) -
Carotid femoral pulse wave velocity in type 2 diabetes and hypertension: capturing arterial health effects of step counts
por: Dasgupta, Kaberi, et al.
Publicado: (2017) -
Sex Differences in Step Count-Blood Pressure Association: A Preliminary Study in Type 2 Diabetes
por: Manjoo, Priya, et al.
Publicado: (2010) -
The Effectiveness of an Annual Nationally Delivered Workplace Step Count Challenge on Changing Step Counts: Findings from Four Years of Delivery
por: Niven, Ailsa, et al.
Publicado: (2021)